1. Skip to content

Category: Research News

  • Cancer Vaccine Holds Promise for Mesothelioma Treatment

    Mesothelioma specialists often pay close attention to emerging cancer treatments to see if they can help in battling this rare disease. Lately, research on vaccines that treat ovarian cancer has captured the attention of many mesothelioma researchers and specialists. Investigators from Massachusetts General Hospital reported in March that a vaccine they are developing to attack …

    Label: Research News Treatment News

    Posted on Sunday, Sep 7, 2014
  • Early Results of Clinical Trial for Defactinib Show Promise for Mesothelioma Patients

    This article is a correction from the original that inadvertently stated that defactinib was approved by the U.S. FDA. It should have said paclitaxel was approved by the FDA. In November, MesotheliomaHelp announced the start of the global clinical trial named COMMAND (Control Of Mesothelioma with MAiNtenance Defactinib), to assess the overall survival and progression …

    Label: Featured Story Research News

    Posted on Monday, Jun 16, 2014
  • Greatwall Protein May be the Key to Stopping Mesothelioma Growth

    Researchers from the Massachusetts Institute of Technology report that metastasis is the cause of nearly 90 percent of cancer deaths, but it remains poorly understood. Understanding how to stop metastasis is critical for increasing survival in mesothelioma, and all cancer patients. Now, in a new study, researchers report they have been able to “decode a …

    Label: Research News

    Posted on Thursday, Oct 17, 2013
Load More News